Apyx medical corporation receives fda clearance for the ayon body contouring system™

The ayon body contouring system is the first fda cleared all-in-one platform for the aesthetic surgical suite plan to initiate the commercial launch of the ayon body contouring system to key opinion leader surgeons in critical geographies during the second half of 2025 clearwater, fla., may 13, 2025 (globe newswire) -- apyx medical corporation (nasdaq:apyx) (“apyx medical”; the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, is pleased to announce it has received 510(k) clearance from the u.s. food and drug administration (the “fda”) for the ayon body contouring system™ (“ayon”).
APYX Ratings Summary
APYX Quant Ranking